BIO Professional Development

Through a curated network of education alliance partners, BIO offers industry professionals executive training and development resources for accelerating career growth

Drug Discovery of Biologics Primer 201

Drug Discovery of Biologics Primer 201 builds upon the foundational knowledge of Drug Discovery of Biologics Primer 101, focusing on systematic insights into therapeutic antibody discovery. This course begins with the significance of antibody screening and structure-based affinity maturation, emphasizing antibody Chemistry, Manufacturing, and Controls (CMC) liabilities. Covering four therapeutic antibody classes, including immune checkpoint inhibitors, this class showcases the factors that influence early drug candidate selection. The data and transition criteria essential for advancing candidate drugs from the discovery phase to preclinical development are also covered. Enroll today to deepen your therapeutic antibody drug discovery knowledge!

black man eagerly does work on laptop

Takeaways

  1. Master the drug discovery workflow and align specific goals for successful development.
  2. Analyze the early drug candidate selection criteria and consider therapeutic antibody properties in the selection process.
  3. Utilize in silicon, in vitro, and in vivo models to investigate functional pharmacological activity.
  4. Demonstrate proficiency in the drug discovery considerations needed for the four distinct classes of antibody therapeutics.
  5. Investigate pharmacology data and transition criteria to determine which drug candidates are progressing into preclinical development. 
Course Price:
$190 USD
BIO Member Price:
$160 USD
Course Length:
45 minutes
Course Level:
Intermediate
Completion Period:
1 year from date of purchase
Course Format:
On-Demand

Certificate Requirements

Complete the course quiz with a passing score of 75% or higher

Suggested Prerequisites
FLIP

Explore biologics discovery: target screening, validation, optimization & transition to preclinical development.

Professional Certificate
Related Courses
FLIP

Explore drug approval process for small molecules & biologics: regulatory bodies, application process, preclinical to clinical studies, final approval.

Professional Certificate
FLIP

A digital strategy can no longer lie within a siloed digital or innovation team. It’s critical to integrate digital across the enterprise to maintain a competitive edge.

FLIP

Do you need to understand the drug development process, including details about a drug's life cycle from its discovery through post-marketing studies?  This is the course for you.

FLIP

Explore biologics discovery: target screening, validation, optimization & transition to preclinical development.

Professional Certificate